Abstract
Because the incidence of organ fibrosis increases with age, various fibrosing disorders are projected to account for significant increases in morbidity, mortality, and healthcare costs in the years to come. Treatments for these diseases are scarce and better understanding of the immunopathogenesis of fibrosis and its relationship to aging are sorely needed. One area of interest in this field is the role that fibrocytes might play in the development of tissue remodeling and fibrosis. Fibrocytes are mesenchymal progenitor cells presumed to be of monocyte origin that possess the tissue remodeling properties of tissue resident fibroblasts such as extracellular matrix production and α-SMA-related contractile properties, as well as the immunologic functions typically attributed to macrophages including production of cytokines and chemokines, antigen presentation, regulation of leukocyte trafficking, and modulation of angiogenesis. Fibrocytes could participate in the development of age-related fibrosing disorders through any or all of these functions. This chapter presents methods that have been developed for the study of circulating human fibrocytes. Protocols for the quantification of fibrocytes in the human circulation will be presented along with discussion of the technical challenges that are frequently encountered in this field. It is hoped that this information will facilitate further investigation of the relationship between fibrocytes, aging, and fibrosis, and perhaps uncover new areas of study in these difficult-to-treat and deadly diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723–737
Murray LA, Rubinowitz A, Herzog EL (2012) Interstitial lung disease: is interstitial lung disease the same as scleroderma lung disease? Curr Opin Rheumatol 24:656–662
Homer RJ, Elias JA, Lee CG et al (2011) Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med 135:780–788
Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345:517–525
Bucala R, Spiegel LA, Chesney J et al (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71–81
Reilkoff RA, Bucala R, Herzog EL (2011) Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 11:427–435
Galligan CL, Siminovitch KA, Keystone EC et al (2009) Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford) 49:640–651
Douglas RS, Afifiyan NF, Hwang CJ et al (2009) Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 95:430–438
Peng X, Mathai SK, Murray LA et al (2011) Local apoptosis promotes collagen production by monocyte-driven cells in transforming growth factor β1-induced lung fibrosis. Fibrogenesis Tissue Repair 4:12–25
Mathai SK, Gulati M, Peng X et al (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 90:812–823
Gan Y, Reilkoff RA, Peng X et al (2011) Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum 63:2484–2494
Moeller A, Gilpin SE, Ask K et al (2009) Circulating fibrocytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:588–594
Mehrad B, Burdick MD, Zisman DA et al (2006) Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 353:104–108
Mehrad B, Burdick MD, Strieter RM (2009) Fibrocyte cxcr4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 41:1708–1718
Schmidt M, Sun G, Stacey MA et al (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171:380–389
Wang CH, Huang CD, Lin HC et al (2008) Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 178:583–591
Nihlberg K, Larsen K, Hultgardh-Nilsson A et al (2006) Tissue fibrocytes in patients with mild asthma: A possible link to thickness of reticular basement membrane? Respir Res 7:50
Vakil V, Sung JJ, Piecychna M et al (2009) Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation. J Magn Reson Imaging 30:1284–1288
Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47:C7–C12
Nikam VS, Wecker G, Schermuly R et al (2011) Treprostinil inhibits adhesion and differentiation of fibrocytes via camp and rap dependent erk inactivation. Am J Respir Cell Mol Biol 45:692–703
Murray LA, Chen Q, Kramer MS et al (2010) Tgf-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid p. Int J Biochem Cell Biol 43:154–162
Phillips RJ, Burdick MD, Hong K et al (2004) Circulating fibrocytes traffic to the lungs in response to cxcl12 and mediate fibrosis. J Clin Invest 114:438–446
Kisseleva T, Uchinami H, Feirt N et al (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45:429–438
Niedermeier M, Reich B, Gomez RM et al (2009) Cd4+ t cells control the differentiation of gr1+ monocytes into fibrocytes. Proc Natl Acad Sci U S A 106:17892–17897
Katebi M, Fernandez P, Chan ES et al (2008) Adenosine a2a receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis. Inflammation 31:299–303
Haudek SB, Cheng J, Du J et al (2010) Monocytic fibroblast precursors mediate fibrosis in angiotensin-ii-induced cardiac hypertrophy. J Mol Cell Cardiol 49:499–507
Haudek SB, Xia Y, Huebener P et al (2006) Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A 103:18284–18289
Haudek SB, Trial J, Xia Y et al (2008) Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc Natl Acad Sci U S A 105:10179–10184
Buday A, Orsy P, Godo M et al (2010) Elevated systemic tgf-beta impairs aortic vasomotor function through activation of nadph oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoe(−/−) mice. Am J Physiol Heart Circ Physiol 299:H386–H395
Xu J, Gonzalez ET, Iyer SS et al (2009) Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow-derived cells can alter the outcome of lung injury in aged mice. J Gerontol A Biol Sci Med Sci 64:731–739
Scholten D, Reichart D, Paik YH et al (2011) Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 179:189–198
Zhang H, Maric I, DiPrima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL (2013) Fibrocytes represent a novel MDSC subset circulating inn patients with metastatic cancer. Blood 122:1105–1113
Van Deventer HW, Wu PQ, Bergsstralh DT, Davis BD, O’Connor BP, Ting J, Serody JS (2008) C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am J Pathol 173:253–264
Van Deventer HW, Palmieri DA, Ping Q, McCook EC, Serody JS (2013) Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2. J Immunol 190:4861–4867
Yang L, Scott PG, Giuffre J et al (2002) Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82:1183–1192
Pilling D, Fan T, Huang D et al (2009) Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 4:e7475
Chesney J, Bacher M, Bender A et al (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive t cells in situ. Proc Natl Acad Sci U S A 94:6307–6312
Bellini A, Mattoli S (2007) The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 87:858–870
Bianchetti L, Barczyk M, Cardoso J et al (2012) Extracellular matrix remodeling properties of human fibrocytes. J Cell Mol Med 3:483–495
Abe R, Donnelly SC, Peng T et al (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556–7562
Pilling D, Buckley CD, Salmon M et al (2003) Inhibition of fibrocyte differentiation by serum amyloid p. J Immunol 171:5537–5546
Castano AP, Lin SL, Surowy T, Nowlin BT et al (2009) Serum amyloid p inhibits fibrosis through fc gamma r-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 1:5ra13
Bellini A, Marini MA, Bianchetti L et al (2011) Interleukin (il)-4, il-13, and il-17a differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol 5:140–149
Shao DD, Suresh R, Vakil V et al (2008) Pivotal advance: Th-1 cytokines inhibit, and th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 83:1323–1333
Moore BB, Murray L, Das A et al (2006) The role of ccl12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 35:175–181
Sakai N, Wada T, Yokoyama H et al (2006) Secondary lymphoid tissue chemokine (slc/ccl21)/ccr7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103:14098–14103
Quan TE, Cowper S, Wu SP et al (2004) Circulating fibrocytes: Collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36:598–606
Lazova R, Gould Rothberg BE, Rimm D et al (2009) The semaphorin 7a receptor plexin c1 is lost during melanoma metastasis. Am J Dermatopathol 31:177–181
Chesney J, Metz C, Stavitsky AB et al (1998) Regulated production of type i collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160:419–425
Balmelli C, Alves MP, Steiner E et al (2007) Responsiveness of fibrocytes to toll-like receptor danger signals. Immunobiology 212:693–699
Hartlapp I, Abe R, Saeed RW et al (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15:2215–2224
Sultana H, Neelakanta G, Foellmer HG et al (2012) Semaphorin 7a contributes to west nile virus pathogenesis through tgf-beta1/smad6 signaling. J Immunol 189:3150–3158
Barth PJ, Ebrahimsade S, Hellinger A et al (2002) Cd34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440:128–133
Barth PJ, Koster H, Moosdorf R (2005) Cd34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol Res Pract 201:301–304
Kraman M, Bambrough PJ, Arnold JN et al (2010) Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330:827–830
Quan TE, Bucala R (2007) Culture and analysis of circulating fibrocytes. Methods Mol Med 135:423–434
Acknowledgements
This work was supported in part by grants R01 HL109033, U01 HL112702-01 (both to E.L.H) from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Hu, X., DeBiasi, E.M., Herzog, E.L. (2015). Flow Cytometric Identification of Fibrocytes in the Human Circulation. In: Shaw, A. (eds) Immunosenescence. Methods in Molecular Biology, vol 1343. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2963-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2963-4_3
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2962-7
Online ISBN: 978-1-4939-2963-4
eBook Packages: Springer Protocols